scholarly article | Q13442814 |
P2093 | author name string | S Sakurai | |
T Fukasawa | |||
A Tanaka | |||
M Fukayama | |||
J M Chong | |||
P2860 | cites work | Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors | Q28118852 |
Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors | Q30303666 | ||
Muscle differentiation and clinicopathologic features of gastrointestinal stromal tumors | Q30311523 | ||
Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats | Q32872145 | ||
W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity | Q34719633 | ||
Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal | Q34747216 | ||
Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal | Q35754561 | ||
Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas | Q35754637 | ||
A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors | Q40997984 | ||
Pacemaker cells in the gastrointestinal tract: interstitial cells of Cajal | Q41049564 | ||
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene | Q47714133 | ||
A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors | Q67741920 | ||
Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases | Q70470140 | ||
Immunohistologic characterization of gastrointestinal stromal tumors: a study of 82 cases compared with 11 cases of leiomyomas | Q70684982 | ||
Gastric adenoma ? carcinoma sequence with special reference to p53 and Ki-ras gene alterations | Q71796173 | ||
Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors | Q71986134 | ||
Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas | Q74576133 | ||
Telomerase activity in gastrointestinal stromal tumors | Q77596968 | ||
KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors | Q77769095 | ||
P433 | issue | 12 | |
P1104 | number of pages | 8 | |
P304 | page(s) | 1321-1328 | |
P577 | publication date | 1999-12-01 | |
P1433 | published in | Japanese Journal of Cancer Research | Q26842384 |
P1476 | title | C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal | |
P478 | volume | 90 |
Q42108961 | A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene |
Q27824814 | A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential |
Q39650027 | A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors |
Q53674961 | A rare case of huge gastrointestinal stromal tumor (GIST) of the stomach extending into the posterior mediastinum. |
Q40751543 | Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance |
Q34512501 | Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor |
Q44490297 | Alterations of the c-kit gene in testicular germ cell tumors |
Q64007381 | Carbazole Derivatives' Binding to c-KIT G-Quadruplex DNA |
Q37099095 | Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours |
Q47271715 | Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors |
Q39070576 | Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab |
Q44549290 | Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors |
Q52023294 | Differentially expressed genes in gastric tumors identified by cDNA array. |
Q44618426 | Endoscopic ultrasonography-guided fine needle aspiration biopsy in follow-up patients with gastrointestinal stromal tumours |
Q44413967 | Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung |
Q42785249 | G-quadruplex-binding benzo[a]phenoxazines down-regulate c-KIT expression in human gastric carcinoma cells |
Q41852979 | Gain-of-Function Mutations of Receptor Tyrosine Kinases in Gastrointestinal Stromal Tumors |
Q38703103 | Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis. |
Q54648663 | Gastrointestinal stromal tumor with dedifferentiation to undifferentiated pleomorphic sarcoma. |
Q34265279 | Gastrointestinal stromal tumors |
Q44435443 | Gastrointestinal stromal tumors. A morphologic and molecular genetic independent tumor entity with new therapeutic perspectives |
Q35553853 | Gastrointestinal stromal tumors: a paradigm for molecularly targeted therapy |
Q46960807 | Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy |
Q35209537 | Gastrointestinal stromal tumors: from a surgical to a molecular approach. |
Q37874125 | Gastrointestinal stromal tumors: molecular mechanisms and targeted therapies |
Q35829580 | Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors |
Q35605747 | Interstitial cells in the musculature of the gastrointestinal tract: Cajal and beyond |
Q44075449 | KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin |
Q37451719 | Kinase inhibitors in cancer therapy |
Q36856506 | Large gastrointestinal stromal tumor size does not imply early recurrence |
Q33629772 | Malignant gastrointestinal stromal tumor of the gallbladder |
Q41901975 | Microfluidic deletion/insertion analysis for rapid screening of KIT and PDGFRA mutations in CD117-positive gastrointestinal stromal tumors: diagnostic applications and report of a new KIT mutation |
Q36475766 | Molecular characterisation of gastrointestinal stromal tumours in a South African population |
Q55246254 | Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese. |
Q35745870 | Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases |
Q73287799 | Mutations of c‐kit at exons 17/13 are rare but clinically relevant in human subjects |
Q36671415 | Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. |
Q34125947 | Neoplasms associated with germline and somatic NF1 gene mutations |
Q35045459 | Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review |
Q81703574 | Patterns of gene amplification in gastrointestinal stromal tumors (GIST) |
Q33712862 | Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis |
Q53398917 | Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland. |
Q42559983 | Selective recognition of a DNA G-quadruplex by an engineered antibody |
Q36978525 | Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions |
Q34547563 | Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy |
Q34174883 | Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? |
Q28344793 | The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors |
Q53561823 | The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST. |
Q28352810 | The histopathological differential diagnosis of gastrointestinal stromal tumours |
Q35588633 | The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated |
Q40208940 | Thy-1 as a potential novel diagnostic marker for gastrointestinal stromal tumors |
Q34103663 | Tyrosine kinases and gastric cancer |
Q44287763 | c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors |
Q45095957 | c-kit gene mutations in intracranial germinomas |
Q77648970 | c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant |